AtreMorine is a natural product of the vegetal line obtained from the vegetal species Vicia Faba L., a natural source of L-dopa, a precursor of the neurotransmitter dopamine.
Benefits and Indications
AtreMorine contributes to cell protection against oxidative stress.
AtreMorine contributes to improving motor function.
AtreMorine contributes to protecting DNA, proteins and lipids against oxidative stress.
- forestalling and treating dopamine deficiency-associated pathologies.
- protecting cells against oxidative stress, involved in the development of many diseases.
- Natural Complex of Vegetal Origin -
AtreMorine is a compound of vegetal origin obtained from the species Vicia Faba L. by non-denaturing biotechnological processes which preserve the natural properties of the active ingredients.
- Natural source of L-dopa -
The species Vicia Faba L. is a natural source of L-dopa, a precursor of the neurotransmitter dopamine.
AtreMorine combines the benefits of vitamin E, providing the recommended daily intake.
1. Rabey JM, Vered Y, Shabtai H, Graff E, Korczyn AD. Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. J Neurol Neurosurg Psychiatry 1992, 55(8):725-7.
2. Kempster PA, Bogetic Z, Secombei JW, Martin HD, Balazs ND, Wahlqvist ML. Motor effects of broad beans (Vicia faba) in Parkinson’s disease: single dose studies. Asia Pac J Clin Nutr 1993, 2(2):85-9.
3. Vered Y, Rabey JM, Palevitch D, Grosskopf I, Harsat A, Yanowski A, Shabtai H, Graff E. Bioavailability of Levodopa after Consumption of Vicia faba Seedlings by Parkinsonian Patients and Control Subjects. Clinical Neuropharmacology 1994, 17 (2).
4. No authors listed. An alternative medicine treatment for Parkinson’s disease: results of a multicenter clinical trial. HP-200 in Parkinson’s Disease Study Group. J Altern Complement Med 1995, 1(3):249-55.
5. Randhir R, Shetty P, Shetty K. L-DOPA and total phenolic stimulation in dark germinated fava bean in response to peptide and phytochemical elicitors. Process Biochemistry 2002, 37: 1247–1256.
6. Randhir R, Shetty K. Microwave-Induced Stimulation of L-DOPA, Phenolics and Antioxidant Activity in Fava Bean (Vicia faba) for Parkinson’s Diet. Process Biochemistry 2004, 39 (11): 1775-1784.
7. Goyoaga C,· Burbano C,·Cuadrado C, Varela A, Guillamón E, Pedrosa MM, Muzquiz M. Content and distribution of vicine, convicine and L-DOPA during germination and seedling growth of two Vicia faba L. varieties. Eur Food Res Technol 2008, 227: 1537-1542.
8. Hornykiewicz O. A brief history of levodopa. J Neurol 2010,257(Suppl 2):S249-52.
9. Emily MG, Tericka SC, Suzanna L, Marcus CF, David R. An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion. Am J Clin Nutr 2013, 97:1144–50.
10. Ahmed SN. Do favic patients resume fava beans ingestion later in their life, a study for this, and a new hypothesis for favism etiology. Hematol Oncol Stem Cell Ther 2013, 6(1):9-13.
11. Mehran SMM, BG. Simultaneous determination of levodopa and carbidopa from fava bean, green peas and green beans by high performance liquid gas chromatography. J Clin Diagn Res 2013, 7(6):1004-7.
12. Malaguti M, Dinelli G, Leoncini E, Bregola V, Bosi S, Cicero AFG, Hrelia S. Bioactive Peptides in Cereals and Legumes: Agronomical, Biochemical and Clinical Aspects. Int J Mol Sci 2014, 15: 21120-21135.
13. Etemadi F, Hashemi M, Xing B, Mashayekhi H. Accumulation Trend of L-Dopa in Different Plant Parts of Fava Beans Varieties. Poster number 553. ASA, CSSA & SSSA International Annual Meeting Nov 2-5, 2014 Long Beach, California.
14. Soares AR, Marchiosi R, Siqueira-Soares Rde C, Barbosa de Lima R, Dantas dos Santos W, Ferrarese-Filho O. The role of L-DOPA in plants. Plant Signal Behav 2014, 9(3): e28275.
15. Ramírez-Moreno JM, Salguero Bodes I, Romaskevych O, Duran-Herrera MC. Broad bean (Vicia faba) consumption and Parkinson’s disease: a natural source of L-dopa to consider. Neurologia 2015, 30(6): 375-6.
Information and data sheet
Nutritional values per capsule
|Nutritional data (per capsule)|
|Vitamine E (tocoferol)||12 mg|
|Energy value||14 kcal (59 kJ)|
Warnings and Precautions
- Food supplements should not be used as a substitute for a balanced diet.
- AtreMorine® must not be taken by persons with an allergy to any of its components.
- AtreMorine® must not be taken by persons with glucose-6-phosphate dehydrogenase enzyme deficiency, a hereditary disease also known as favism.
- Persons taking monoamine oxidase enzyme-inhibiting antidepressants should consult their physician before taking AtreMorine.
- Keep out of the reach of children.
- Bottle with 75g.
Content per dose:
EFava-Lin-10729® extract, 4.967 g
Natural vitamin E (D-alfa tocopheryl acetate) 0.033 g
Equivalent to 12 mg vitamin E*
*Recommended daily intake
- Keep in a cool, dry place.
- Mix 2 spoonfuls of AtreMorine (equivalent to 5 g) with food per dose.
Ask your physician or pharmacist about the health benefits of taking these nutrients as part of your daily diet.